Int. J. Cancer: 113, (2005) 2004 Wiley-Liss, Inc.

Size: px
Start display at page:

Download "Int. J. Cancer: 113, (2005) 2004 Wiley-Liss, Inc."

Transcription

1 Int. J. Cancer: 113, (2005) 2004 Wiley-Liss, Inc. HPV-Associated Flat Penile Lesions in Men of a Non-STD Hospital Population: Less Frequent and Smaller in Size than in Male Sexual Partners of Women with CIN Maaike C.G. Bleeker 1, Cornelis J.A. Hogewoning 4, Feja J. Voorhorst 2, Adriaan J.C. van den Brule 1, Johannes Berkhof 2, Albertus T. Hesselink 1, Marjolein Lettink 1, Theo M. Starink 3, Tom J. Stoof 3, Peter J.F. Snijders 1 and Chris J.L.M. Meijer 1 * 1 Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands 2 Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands 3 Department of Dermatology, VU University Medical Center, Amsterdam, the Netherlands 4 Department of Gynaecology and Obstetrics, Albert Schweitzer Hospital, Dordrecht, the Netherlands Human papillomavirus (HPV) infections and HPV-associated penile lesions are frequently found in male sexual partners of women with cervical intraepithelial neoplasia (CIN). To determine the significance of these findings, we studied the prevalence of HPV and HPV associated penile lesions in a male hospital population with non-std complaints. Penoscopy was performed after application of acetic acid to identify flat lesions, papular lesions, condylomata acuminata and pearly penile papules (PPPs). Presence of HPV DNA in penile scrapes was tested by GP5 6 PCR. In case of HPV 16 positivity, viral loads were quantified using a LightCycler based real-time PCR method. Comparing the non-std male hospital population (n 118) with the male sexual partners of women with CIN (n 238), flat penile lesions were found in 14% vs. 60% and penile HPV in 25% vs. 59% of the men, respectively. We found that the presence of penile HPV and, in case of HPV 16 positivity, higher viral loads were associated with the presence of flat penile lesions. Amongst the HPV-positive men, flat penile lesions were more common and larger in size in male sexual partners of women with CIN than in the non-std hospital population. HPV infections and HPV-associated flat penile lesions are commonly found in the non-std male population. However, these lesions are less frequently present and smaller in size than in male sexual partners of women with CIN. Higher viral loads in penile scrapes of male sexual partners of women with CIN are reflected by a higher prevalence of flat penile lesions and a larger size of these lesions Wiley-Liss, Inc. Key words: penile HPV; viral load; flat penile lesions Extensive research in women during the past decades has led to the conclusion that sexually transmitted human papillomavirus (HPV) infection is etiologically linked to precancerous and invasive neoplastic lesions of the cervix. In fact, high-risk types of HPV have been detected in 99.7% of the cervical carcinomas. 1 Multiple studies have reported a role for the male sexual partner in the epidemiology of carcinoma of the cervix. 2 4 However, studies on penile lesions and HPV infection in men are scarce and have been mainly restricted to high risk populations such as those visiting clinics for sexually transmitted diseases (STD) or male partners of women with HPV-associated diseases These studies, mainly reported from the late 1980s to the early 1990s, showed a wide spectrum of HPV-associated penile lesions varying from classical condylomata acuminata to lesions consistent with severe penile intraepithelial neoplasia (PIN). More recently, we described penile lesions in 68% of the male sexual partners of women with cervical intraepithelial neoplasia (CIN). 11 Most of these lesions were flat and could be clearly visualised only after application of acetic acid. By polymerase chain reaction (PCR), HPV DNA was detected in 59% of the corresponding penile scrapes. Interpretation of these findings, however, was hampered by lack of data about HPV infections and HPV-associated penile lesions in men from the general population. These data are necessary to obtain sufficient insight in the epidemiology and clinical manifestations of HPV infection in men. Here we present data about penile lesions and presence of HPV in a male non-std hospital population. The findings were compared to data in male sexual partners of women with CIN. In case of HPV 16 positivity, viral DNA loads were quantified and related to the presence of flat penile lesions. Material and methods Population A From April 2002 until November 2002, men between 18 and 75 years, visiting the outpatient non-std clinic of the Department of Dermatology of the VU Medical Center in Amsterdam were asked to participate in the study. Not eligible were men who consulted the clinic because of a sexually transmitted disease or those having anogenital cancer. Of 181 eligible men, 156 were willing to participate. These men visited the Department of Dermatology because of nongenital skin cancer screening (n 21), pigmented naevi (n 21), eczema (n 28), allergy (n 20), psoriasis (n 17), nongenital warts (n 8), syndrome related skin disorders (n 6), itching (n 4), acne (n 4) or other nongenital dermatological problems (n 27). Of the 156 men of the non-std hospital population, 118 (76%) did have a female partner and 38 (24%) did not. In the latter population 4 men reported a male partner and 34 no steady relationship. In the present study, only findings of men with a female partner were presented (population A). The presence of CIN in the female partners of these men was not evaluated and therefore unknown. However, men were asked for the presence of abnormal cervical cytology and other cervical problems in their partner. Population B Male sexual partners of women with CIN (n 238) were recruited at the colposcopy clinic of the Albert Schweitzer hospital in Dordrecht (the Netherlands) from December 1995 to June Details of the latter group of men have been described elsewhere. 11,12 Penoscopic findings and HPV detection in penile scrapes from 175 of the 238 men with a female partner with CIN were previously published. 11 The study protocols were approved by the ethics review board of the hospitals and all participants signed informed consent. Specimen collection and penoscopic examination For HPV testing, a Cervex brush was used to collect cells from the top of penis (including the glans, corona, sulcus, frenulum and the inner part of the foreskin). The brush was collected in a phosphate-buffered saline solution, sent to the laboratory and Abbreviations: CI, confidence interval; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus; OR, odds ratio; PCR-EIA, polymerase chain reaction-enzyme immunoassay; STD, sexually transmitted disease. Grant sponsor: ZON-MW; Grant number: Dr. A.J.C. van den Brule s current address is: Laboratory for Pathology, PAMM Institute, Eindhoven, The Netherlands. *Correspondence to: Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, the Netherlands. Fax: cjlm.meijer@vumc.nl Received 9 May 2004; Accepted after revision 7 June 2004 DOI /ijc Publishedonline25August2004inWileyInterScience( wiley.com). Publication of the International Union Against Cancer

2 HPV INFECTION AND FLAT PENILE LESIONS IN MEN 37 stored at 4 C until processing. After penile scraping and several minutes after the application of 3% acetic acid solution, penoscopy was performed to identify lesions. For penoscopy, a colposcope was used with a magnification factor ranging from 6 to 16 times (Olympus OCS-AW4) and findings were documented by photographs. Penile lesions were classified as flat lesions, papular lesions and condylomata acuminata as described and illustrated earlier. 11 When penile lesions were present, it was estimated whether the total area of penile epithelium affected was smaller or larger than 5 mm 2 in size. In addition, the presence of pearly penile papules, a normal benign variation, was administrated. HPV detection After vortexing, suspensions of penile scrapes were centrifuged, resuspended in 100 to 200 L TE (10 mmol/l TRIS, 1 mmol/l EDTA, ph 7.5) and stored at 80 C until use. Initially, aliquots of 10 L of crude extracts were used for GP5 /6 enzyme immunoassay (EIA) PCR, as described previously. 13,14 This method enables group detection of 14 high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) and 23 low-risk types (6, 11, 26, 34, 40, 42, 43, 44, 53, 54, 55, 57, 61, 70, 71, 72, 73, 81, 82/MM4, 82/MM4, 83, 84 and CP6108) by using a high-risk and low-risk oligoprobe cocktail, respectively. On HPV-positive cases, individual typing was performed for high-risk HPV 16, 18, 31 and 33, and for low-risk HPV 6 and 11, using type specific probes in an EIA format. All HPV PCR-negative samples were subjected to a -globin PCR, as DNA quality control of the sample. Specimens that were negative in both HPV and -globin PCR assays were excluded from the HPV analyses because of inadequate sample quality. In order to select samples to be used for subsequent HPV 16 viral load assessment, DNA was extracted from half of the penile scrape suspension left using the HPPTP kit (Roche, Mannheim, Germany). These samples were subjected to another GP5 6 PCR EIA round followed by typing specific for HPV 16. Quantification of HPV 16 and -globin by a LightCycler based real-time PCR Viral load testing of HPV 16 positive purified DNA extracts was done using a LightCycler based real-time HPV 16 type specific PCR method, as described by Hesselink et al. (manuscript in preparation). For this assay, primers and probes had been selected within the E7 region. Sequences of HPV 16 oligonucleotides were the following: forward PCR primer 5 -gaggaggaggatgaaatagatggt- 3 (nt position ), reverse PCR primer 5 -gcccattaacaggtcttccaa-3 (nt position ), donor probe 5 -acaaaaggttacaatattgtaatgggctct-3 fluorescence (nt position ) and acceptor probe red ccggttctgcttgtccagctgg-3 (nt position ). Amplification of the -globin gene was used to quantify the amount of cellular DNA per sample. Sequences of -globin oligonucleotides were the following: forward PCR primer 5 -gagccatctattgcttacatttgc-3 (nt position ), reverse PCR primer 5 -ttggtctccttaaacctgtcttgt-3 (nt position ), donor probe 5 -ccagggcctcaccaccaacttc-3 fluorescence (nt position ) and acceptor probe red ccacgttcaccttgccccacag-3 (nt position ). For quantification of HPV 16, standard curves were generated using 10-fold dilutions of HPV 16 plasmid (ranging from 10 to 100,000 fg per reaction) spiked in 100 ng human placenta DNA (hpdna). The -globin gene was quantified with the aid of standard curves of 10-fold dilutions of hpdna ranging from 3 pg to 30 ng per reaction. LightCycler tests were run in duplicate and data were averaged for ultimate calculation of viral load. Statistical analysis Between the populations (population A vs. B), potential differences in age, circumcision rate and ethnicity were examined using t-tests, chi-square tests and Fisher exact tests, where appropriate. Odds ratios (OR) and 95% confidence intervals (CI) were computed of the prevalence of penile lesions and HPV. Stratified analyses were performed to adjust for age differences between 2 populations. 15 Each population was divided in homogeneous age-strata ( 35, and 45years) and the OR was computed for each stratum separately. As a following step, Breslow and Day s test of homogeneity was applied to check whether the stratum-specific ORs could be pooled into the Mantel Haenszel s common odds ratio (OR MH ). 16 An analogous approach was used restricting the stratified analyses to men who were not circumcised. Determinants for flat penile lesions and penile HPV were estimated within each cohort using logistic regression analyses. Viral load values were analysed both as continuous and categorised variables, using Mann-Whitney or 2 tests, respectively. HPV 16 positive samples which were negative in LightCycler PCR tests, thus containing number of HPV copies or cells under the detection level, were set at 10 copies or 5 cells input, respectively 13 (Hesselink et al., manuscript in preparation). Ten copies input per PCR reaction corresponds to approximately 250 copies per penile scrape. Analysing HPV copies per cell, samples were excluded when both number of HPV 16 copies and cells were under the detection level. Level of statistical significance was set at 0.05 (2-sided). Results Characteristics of the study populations Population A. Of the 118 men of the non-std hospital population with a female partner, the mean age was 46.1 years (range ). Circumcised were 21 (17.8%) men and non-caucasian were 13 (11%) men. Population B. Male sexual partners of women with CIN (n 238) averaged 37.6 years (range ). Eleven (5%) of them were circumcised and 13 (5%) men were non-caucasian. In population B, the mean age was lower and less widely ranged (p 0.001) and less men were circumcised compared to population A (p 0.001). Number of non-caucasian men in population B was not significantly different from population A (p 0.058). Penile lesions, HPV detection, and HPV 16 viral load Penile lesions. Flat penile lesions were found in 16 (14.3%) men of population A (Table I). In 5 (31.3%) of these men more than 5 mm 2 of the penile epithelium was affected. Condylomata acuminata were not found in this population. Papular lesions were found in 23 (20.5%) and PPPs in 27 (24.1%) men. Flat penile lesions were found in 139 (60.4%) men of population B which was significantly more prevalent compared to population A (OR MH 9.6, 95% CI ). Flat penile lesions in population B sized more than 5 mm 2 in 75% of the men indicating a higher number of men with larger sized lesions than in population A. Condylomata acuminata were found in 11 (4.8%) men, which was significantly more prevalent than in population A (p 0.019). Papular lesions and PPPs were found in 49 (21.3%) and in 79 (34.3%) men, respectively. The prevalences of papular lesions and PPPs were not significantly different in both populations. Not suitable for penoscopic evaluation due to previous surgery or phimosis were 6 (5.1%) men of population A and 8 (3.4%) men of population B. HPV detection. HPV DNA was detected in 21 (25.3%) penile scrapes of population A (Table I) vs. 101 (59.4%) in population B (OR MH 4.2, 95% CI ). Proportions of penile scrapes that were negative in both HPV and -globin PCR assays were similar in the populations, i.e., 29.7% in population A and 28.6% in population B. In HPV-positive individuals, infection with a single HPV type was most common, i.e., 16 (76.2%) men of population A and 81 (80.2%) men of population B (Table II). In both populations, infection with high-risk types was more prevalent than infection with low-risk types. However, HPV 16 was less frequently detected in population A than in population B, i.e., in 4 (19.0%) vs. 47 (46.5%) men, respectively (p 0.028). Low-risk types were more frequently found in population A than in population B, i.e., in 10 (47.6%) and in 32 (31.7%) men but this difference was not statistically significant (p 0.257).

3 38 BLEEKER ET AL. TABLE I PREVALENCE OF PENILE LESIONS AND PENILE HPV IN THE MALE NON-STD HOSPITAL POPULATION (A) AND IN MALE SEXUAL PARTNERS OF WOMEN WITH CIN (B) Population A (N %) B (N %) A vs. BOR MH A vs. B uncircumcised OR (95% CI) 1 MH (95% CI) 1 Subjects Penoscopic findings Not suitable for evaluation Flat penile lesions No reference 1.0 reference Yes ( ) 7.8 ( ) Condylomata acuminata No Yes Papular lesions No reference 1.0 reference Yes ( ) 1.1 ( ) PPPs No reference 1.0 reference Yes ( ) 1.3 ( ) Penile HPV detection GP5 /6 HPV PCR EIA Not determined HPV negative reference 1.0 reference HPV positive ( ) 3.7 ( ) 1 Age-stratified analyses ( 35; 35 45; 45 years) were performed to calculate the Mantel Heanzsel s common odds ratio (OR MH ) and the 95% confidence interval (CI). Boldface numbers indicate statistical significance (p 0.05). 2 Not suitable for penoscopic evaluation due to previous surgery or phimosis. 3 Not determined due to samples negative in both the -globine and HPV PCR tests. 4 Not calculated (fisher exact testavsbp 0.019; A vs B uncircumcised p 0.062). TABLE II CHARACTERISTICS OF PENILE HPV INFECTION IN THE MALE NON-STD HOSPITAL POPULATION (A) AND IN THE MALE SEXUAL PARTNERS OF WOMEN WITH CIN (B) 1 Population A (N %) B (N %) A vs. B p HPV positive subjects Single genotype Multiple genotypes High-risk genotype other high-risk Low-risk genotype other low-risk Chi-squared tests or fisher exact tests were used. Boldface numbers indicate statistical significance (p 0.05). TABLE III PENILE HPV 16 VIRAL LOAD IN MEN OF THE NON-STD HOSPITAL POPULATION (A) AND IN MALE SEXUAL PARTNERS OF WOMEN WITH CIN (B) Population A (N %) B (N %) A vs. B p HPV 16 positive subjects HPV copies/scrape HPV copies/scrape The p value was calculated using the Fisher exact test. Boldface number indicated statistical significance (p 0.05). HPV 16 viral load Compared to HPV testing of crude extracts, higher numbers of HPV 16-positive penile scrapes were found after testing purified DNA extracts indicating the higher analytical sensitivity of the GP5 6 PCR assay using purified DNA. 17 HPV 16 was detected in purified DNA extracts of 20 penile scrapes of population A and in 58 scrapes derived from population B. HPV 16 DNA quantification of these samples showed that less HPV 16 copy numbers were found in scrapes derived from population A compared to those from population B (Table III). One out of the 58 HPV 16-positive men of population B could not be tested for viral load due to insufficient sample material. Eighteen of 20 (90.0%) tested samples of population A yielded 10 HPV copies input, corresponding with less than 250 HPV 16 copies per scrape (range 250 2,712). This proportion was significantly lower (p 0.024) in population B, i.e., 35/57 (61.4%) samples counted less than 250 copies (range ,026; p 0.015). When only scrapes with 250 copies were considered, a median of 1,572 copies (range 432 2,712; n 2) was found in penile scrapes of population A vs. 2,834 copies (range ,026; n 22) in scrapes of population B (p 0.35). A median of 1.2 copies per cell

4 HPV INFECTION AND FLAT PENILE LESIONS IN MEN 39 (range ; n 8) was found in scrapes of population A vs. 5.0 copies per cell (range ; n 28) in population B (p 0.033). Twelve of 20 (60%) samples from population A and 29/57 (51%) samples from population B yielded both 10 copies and 5 cells input and were therefore excluded from the analyses on HPV 16 copy numbers per cell. Determinants of flat penile lesions and penile HPV Determinants of flat penile lesions are presented in Table IV. The positive association between the presence of penile HPV and the presence of flat penile lesions was found both in population A (OR 6.4, 95% CI ) and in population B (OR 3.2, ). Both in HPV-positive and in HPV-negative men, rates of flat penile lesions were higher in population B than in population A. Considering HPV-positive subjects, flat penile lesions were found in 77.1% in population B vs. 42.1% in population A (OR MH 4.7, 95% ). In HPV-negative men, these figures were 51.5% vs. 10.2%, respectively (OR MH 8.3, 95% ). Age was not related to the presence of flat penile lesions. In population A, all flat penile lesions were found among uncircumcised men and none among those circumcised (p 0.069). Neither age nor circumcision was associated with the presence of penile HPV. In population A, HPV positive were 6/19 (31.1%) men 35 years, 7/24 (29.2%) men between 35 and 45 years (OR 0.9, 95% CI ) and 8/40 (20.0%) men 45 years (OR 0.5, 95% CI ). In population B, these figures were 41/71 (57.7%), 38/65 (58.5%; OR 1.0, 95% CI ) and 22/34 (64.7%; OR 1.3, 95% CI ), respectively. HPV positive were 18/70 (25.7%) uncircumcised and 3/13 (23.1%) circumcised men (OR 0.9, 95% CI ) from population A. In population B, 93/160 (58.1%) uncircumcised and 8/10 (80.0%; OR 2.9, 95% CI ) circumcised men were HPV positive. The association between HPV 16 viral load and flat penile lesions When HPV 16-positive subjects were considered, more HPV 16 copies were present in scrapes derived from men with flat penile lesions compared to those without (Table V). Per scrape, all HPV 16-positive men without flat penile lesions (n 28) yielded less than 250 HPV 16 copies vs. 267 (range ,026; n 45) when flat penile lesions were present (p 0.001). Per cell, the median copy number was 0.7 (range ; n 4) when lesions were absent vs. 4.3 (range ; n 31) when lesions were present (p 0.070). In population A, 100% of the penile scrapes of men without flat penile lesions yielded less than 250 HPV 16 copies (n 15) vs. 60% when lesions were present (range 250 2,712; n 5; p 0.012). Median copies per cell were 1.1 (range ; n 3) and 1.4 (range ; n 5), respectively (p 0.9). In population B, these figures were 250 copies per scrape when lesions were absent (n 13) vs. 342 copies per scrape (range ,026; n 40) when lesions were present (p 0.001). Copies per cell were 0.3 (n 1) vs. 5.0 (range ; n 26), respectively (p 0.2). Besides the presence of higher viral loads when flat penile lesions are present these data suggest that, in case of prevalent flat penile lesions, higher viral loads are present in penile scrapes of population B than in those of population A. However, these differences were not statistically significant (p for copies per scrape and p for copies per cell). Discussion In order to determine the significance of the high prevalence of penile HPV DNA and HPV-associated penile lesions in male sexual partners of women with CIN, we evaluated a male non-std population, visiting the outpatient clinic of the Department of Dermatology as a representative of the general male population in the Netherlands. Besides the lower prevalence of penile HPV and HPV-associated penile lesions, lower HPV 16 viral loads were found in penile scrapes of this non-std hospital population compared to the group of male sexual partners of women with CIN. Consistent with the presence of lower viral loads, we found that flat penile lesions were not only less frequently observed but also smaller in size in the non-std hospital population than in male sexual partners of women with CIN. Our findings on the prevalence of flat penile lesions in both populations are consistent with data presented in literature. Based on small populations, published rates of flat penile lesions found in male partners of women without HPV-associated lesions range from 2 to 21%. 6,10,18,19 The highest rate was found in a hospital-based population of nearly a hundred men attending an infertility clinic. 19 The lower rates were found in male partners of women with non-hpv-related gynaecologic problems, 18 chlamydial cervicitis 10 or normal cytology in their cervical smears. 6 For male partners of women with abnormal cervical cytology, rates between 50% and 63% have been reported. 6,8,10,18 Besides the lower prevalence of flat penile lesions, we found that lesions sized smaller in the non-std hospital population than in the male sexual partners of women with CIN. The prevalence of condylomata acuminata in the populations investigated was low though our findings indicate that they were more prevalent in male sexual partners of women with CIN. This difference however might be biased as men of Population TABLE IV DETERMINANTS FOR FLAT PENILE LESIONS IN MEN OF THE NON-STD HOSPITAL POPULATION (A) AND IN MALE SEXUAL PARTNERS OF WOMEN WITH CIN (B) 1 Total N A Flat OR (95% CI) Total Flat N % N N % B OR (95% CI) Subjects Penile HPV Not in analyses Negative Reference Reference Positive ( ) ( ) Age 35 years Reference Reference years ( ) ( ) 45 years ( ) ( ) Circumcision No Reference Yes ( ) 1 Logistic regression analyses were performed to estimate the odds ratio (OR) and 95% confidence interval (CI). Boldface numbers indicate statistical significance (p 0.05). 2 Subjects with condylomata acuminata only or those who were not suitable for penoscopic examinations due to previous surgery or phymosis were excluded. 3 Not determined were samples which were negative in both the -globine and HPV PCR tests. ***Not calculated (fisher exact test p 0.069).

5 40 BLEEKER ET AL. TABLE V RELATION BETWEEN THE PRESENCE OF FLAT PENILE LESIONS AND HPV 16 VIRAL LOAD IN HPV 16 POSITIVE PENILE SCRAPES FROM MEN OF THE NON-STD HOSPITAL POPULATION (A) AND IN MALE SEXUAL PARTNERS OF WOMEN WITH CIN (B) 1 Population A B A B Flat lesions at penoscopy Flat Flat Flat Flat Flat Flat p p N % N % N % N % N % N % Subjects Number of HPV 16 copies Under detection level ( 250) < Above detection level ( 250) Per scrape (median/range) / ,026.4 <0.001 Per cell (median/range) 3 0.7/ / P values were calculated using fisher exact tests for categorical variables and Mann-Whitney tests for continues variables. Boldface numbers indicate statistical significance (p 0.05). 2 subjects with condylomata acuminata only or those who were not suitable for penoscopic examinations due to previous surgery or phymosis were excluded. 3 samples yielding 10 copies and 5 cells input were excluded in these analyses (in analyses A B: men without flat n 4 and men with flat n 31). p the non-std population were considered not eligible to participate in this study when the clinic was visited because of a sexual transmitted disease, for example, genital condylomata. On the other hand, one would expect an elevated rate of genital condylomata in male sexual partners of women with CIN because infections with both high- and low-risk HPV types share identical sex-related risk factors. 20 In both populations, we found similar rates of PPPs and papular lesions. These findings support earlier observations that there exists no association between HPV and these penile features. 12,21,22 As earlier described by us for male sexual partners of women with CIN, 11 the association between the presence of flat penile lesions and HPV detection in penile scrapes was also found in men of the non-std hospital population who had a female partner. Consistent with the lower prevalence of flat penile lesions, penile HPV was less frequently detected in men of the non-std population compared to those having a female partner with CIN. Case-control studies in populations at high (Colombia) and low (Spain) risk for cervical cancer have also found higher rates of penile HPV in husbands of women with cervical neoplasia compared to those without. 3 However, in comparison to our study, lower rates of penile HPV were reported in these studies. Using PCR techniques, HPV was detected in 17% of the case patients and in 5% of the control subjects in Spain and these rates were 26% and 19%, respectively, in Colombia. In part this could be due to the fact that a different PCR method was used for these studies. Additionally, in these studies, penile sampling included the distal urethra as well as the external surface of the penis. A low prevalence of HPV and HPV-associated lesions in the urethra in combination with a more easy collection of cells sampled from this nonkeratinised site of the penis may be responsible for this apparently lower HPV detection rate. Considering HPV-positive subjects, the majority was positive for a high-risk type. However, HPV 16 was less frequently detected in men of the non-std population than in male sexual partners of women with CIN. Interestingly, this difference was less pronounced using purified extracts. In our experience, the use of purified DNA enables detection of lower viral loads, i.e., the method has a higher analytical sensitivity compared to crude extracts. 17 Apparently, higher viral loads are present in male sexual partners of women with CIN. Indeed, HPV 16 viral load quantification on purified DNA showed that higher copy numbers were present in penile scrapes of male sexual partners of women with CIN than in those of the non-std male population. The presence of higher viral loads is a likely explanation for the finding that flat penile lesions were not only more common but also larger in size in male partners of women with CIN. This is substantiated by the observed association between viral load and flat penile lesions. All HPV 16-positive subjects without flat penile lesions yielded low levels of HPV copy numbers whereas higher numbers were found in scrapes of men with flat penile lesions. These findings indicate that a considerable part of penile HPV infections do not result in development of penile lesions. The non-std population was composed of men who visited a non-std Department of Dermatology, who were generally in good health and who were not selected for age or other specific characteristics that might be HPV related. The advantage of this approach was that these men were likely to have a similar risk for HPV infections and related lesions as a general male population in the Netherlands. However, the consequence is that this study group did not match with the population of men selected on the basis of a prevalent CIN lesion in the female partner. Indeed, substantial differences between both populations were present for age and history of circumcision. Possible bias due to this selection however is unlikely because our analyses showed very similar risk estimates for the presence of penile lesions and HPV after adjustment for these demographic characteristics. Moreover, both cohorts showed no particular relationship between age and the presence of flat penile lesions or HPV. Therefore, it is more likely that the observed difference in HPV prevalence is owing to the presence vs. absence of a female partner with CIN and consequently a differential risk of being exposed to HPV of the sexual partner. Lack of association between age and penile HPV has also been described by others. 3,26,27 On the contrary, in women HPV prevalence is age related In Dutch women with normal cytology, the HPV prevalence is decreasing from 20% in women aged between 20 and 24 years to 6% in women over 30 years. 28 An HPV prevalence of 25% in non-std men with a mean age of 46 years suggests that HPV infection is more common among men than among women, especially when taken into account that the number of HPV copies collected in penile scrapes is much lower compared to those collected from the cervix and might result in false negativity when testing penile scrapes. Our data indicate that the presence of flat penile lesions is related to the presence of higher viral loads of HPV, whereas HPV detection without the presence of flat penile lesions indicates very low levels. Therefore, identification of flat penile lesions is highly informative in the evaluation of HPV infection in men. In conclusion, penile HPV detection and HPV-associated flat penile lesions are not uncommon in the male non-std hospital population but were significantly less prevalent than in male sexual partners of women with CIN. Detection of penile HPV without the presence of HPV-associated lesions indicates very low levels of HPV DNA. The presence of higher viral loads in penile scrapes of male sexual partners of women with CIN explains not only the higher prevalence of flat penile lesions but also the larger size of these lesions. Acknowledgements We thank P.M. van Diemen for her excellent technical assistance on DNA purification and HPV testing. The medical doctors of the outpatient clinic of the Department of Dermatology are gratefully thanked for the introduction of their male patients.

6 HPV INFECTION AND FLAT PENILE LESIONS IN MEN Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [see comments]. J Pathol 1999;189: Maymon R, Bekerman A, Werchow M, Maymon BB, Segal R, Faktor JH. Clinical and subclinical condyloma rates among male sexual partners of women with genital human papillomavirus infection. J Reprod Med 1995;40: Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997;176: Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002;346: Rosemberg SK, Greenberg MD, Reid R Sexually transmitted papillomaviral infection in men. Obstet Gynecol Clin North Am 1987;14: Barrasso R, de Brux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med1987;317: Aynaud O, Ionesco M, Barrasso R. Penile intraepithelial neoplasia. Specific clinical features correlate with histologic and virologic findings. Cancer 1994;74: Hippelainen M, Yliskoski M, Saarikoski S, Syrjanen S, Syrjanen K. Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy [See Comments]. Genitourin Med 1991;67: Hippelainen MI, Syrjanen S, Hippelainen MJ, Saarikoski S, Syrjanen K. Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation [see Comments]. Genitourin Med 1993;69: Campion MJ, McCance DJ, Mitchell HS, Jenkins D, Singer A, Oriel JD. Subclinical penile human papillomavirus infection and dysplasia in consorts of women with cervical neoplasia. Genitourin Med 1988; 64: Bleeker MC, Hogewoning CJ, van den Brule AJ, Voorhorst FJ, van Andel RE, Risse EK, Starink TM, Meijer CJ. Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002;47: Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Snijders PJ, Starink TM, Berkhof J, Meijer CJ. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003;107: Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JMA General Primer GP5 /GP6( )-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35: van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5 /6 PCR followed by reverse line blot analysis References enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40: Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press, Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2003;201: Bergman A, Nalick R. Prevalence of human papillomavirus infection in men. comparison of the partners of infected and uninfected women. J Reprod Med 1992;37: Pakendorf UW, Bornman MS, Du Plessis DJ. Prevalence of human papilloma virus in men attending the infertility clinic. Andrologia 1998;30: Zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36: Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, van Andel RE, Risse EK, Starink TM, Meijer CJ. Pearly penile papules: still no reason for uneasiness. J Am Acad Dermatol 2003;49: Ferenczy A, Richart RM, Wright TC. Pearly penile papules: absence of human papillomavirus DNA by the polymerase chain reaction. Obstet Gynecol 1991;78: Krebs HB. Genital HPV infections in men. Clin Obstet Gynecol 1989;32: Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993;20: Aynaud O, Ionesco M, Barrasso R. Cytologic detection of human papillomavirus DNA in normal male urethral samples. Urology 2003; 61: Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf-Neto J, Shah KV, Snijders PJ, Meijer CJ, Bosch FX, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002;86: Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, Hallum JA, Redmond SA, Giuliano AR. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003;187: Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53: Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GF, van Kemenade FJ, Verheijen RH, van Groningen K, Boon ME, Keuning JF, van Ballegooijen M, et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004;110: Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions British Journal of Cancer (2005) 92, 1388 1392 All rights reserved 0007 0920/05 $30.00 www.bjcancer.com HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile

More information

CONDOM USE PROMOTES REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CLEARANCE OF HUMAN PAPILLOMAVIRUS: A RANDOMIZED CLINICAL TRIAL

CONDOM USE PROMOTES REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CLEARANCE OF HUMAN PAPILLOMAVIRUS: A RANDOMIZED CLINICAL TRIAL Int. J. Cancer: 107, 811 816 (2003) 2003 Wiley-Liss, Inc. Publication of the International Union Against Cancer CONDOM USE PROMOTES REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CLEARANCE OF HUMAN

More information

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004

The Korean Journal of Cytopathology 15 (1) : 17-27, 2004 5 The Korean Journal of Cytopathology 5 () : 7-7, / 5 / / (human papillomavirus, HPV), 6%, 5% HPV. HPV HPV. HPV HPV,,5 HPV HPV. HPV, 6 HPV. HPV HPV International Agency for Research on Cancer (IARC) HPV

More information

No HPV High Risk Screening with Genotyping. CPT Code: If Result is NOT DETECTED (x3) If Results is DETECTED (Genotype reported)

No HPV High Risk Screening with Genotyping. CPT Code: If Result is NOT DETECTED (x3) If Results is DETECTED (Genotype reported) CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 117 August 6, 2013 HPV High Risk Screening with Genotyping Contact: Dr. Jeffrey Wisotzkey, 717-851-1422 Director, Molecular Pathology

More information

Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5 /6 PCR Method in a Population-Based Cervical Screening Program

Cross-Sectional Comparison of an Automated Hybrid Capture 2 Assay and the Consensus GP5 /6 PCR Method in a Population-Based Cervical Screening Program JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2006, p. 3680 3685 Vol. 44, No. 10 0095-1137/06/$08.00 0 doi:10.1128/jcm.02078-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Cross-Sectional

More information

Human Papillomavirus Detection by Penile Site in Young Men From Kenya

Human Papillomavirus Detection by Penile Site in Young Men From Kenya Sexually Transmitted Diseases, November 2007, Vol. 34, No. 11, p.000 000 DOI: 10.1097/OLQ.0b013e318065b8ef Copyright 2007, American Sexually Transmitted Diseases Association All rights reserved. Human

More information

The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics in Hong Kong

The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics in Hong Kong Hong Kong J. Dermatol. Venereol. (2011) 19, 6-13 Original Article The prevalence of human papilloma virus in the anal region of male Chinese attendees in three public sexually transmitted disease clinics

More information

Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs

Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs Int. J. Cancer: 120, 1505 1510 (2007) ' 2006 Wiley-Liss, Inc. Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening

More information

Chapter 5. M.G. Dijkstra L. Rozendaal M. van Zummeren F.J. van Kemenade P.J.F. Snijders C.J.L.M. Meijer J. Berkhof. Submitted for publication

Chapter 5. M.G. Dijkstra L. Rozendaal M. van Zummeren F.J. van Kemenade P.J.F. Snijders C.J.L.M. Meijer J. Berkhof. Submitted for publication Chapter 5 CIN3 and cancer risks after primary HPV DNA testing and cytology triage in cervical cancer screening: fifteen years follow-up of a randomized controlled trial M.G. Dijkstra L. Rozendaal M. van

More information

FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION

FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION Arch. Biol. Sci., Belgrade, 66 (4), 1653-1658, 2014 DOI:10.2298/ABS1404653M FREQUENCY AND RISK FACTORS OF CERVICAL Human papilloma virus INFECTION IN WOMEN IN MONTENEGRO GORDANA MIJOVIĆ 1, TATJANA JOVANOVIĆ

More information

Chapter 6. Submitted for publication

Chapter 6. Submitted for publication Chapter 6 CADM1 and MAL promoter methylation levels in hrhpv-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease Submitted for publication Mariska Bierkens

More information

Clinical Performance of Roche COBAS 4800 HPV Test

Clinical Performance of Roche COBAS 4800 HPV Test JCM Accepts, published online ahead of print on 9 April 2014 J. Clin. Microbiol. doi:10.1128/jcm.00883-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 1 2 3 4 5 6 Clinical

More information

NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS INFECTION AMONG YOUNG MEN FROM KISUMU, KENYA. Danielle Marie Backes

NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS INFECTION AMONG YOUNG MEN FROM KISUMU, KENYA. Danielle Marie Backes NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS INFECTION AMONG YOUNG MEN FROM KISUMU, KENYA Danielle Marie Backes A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in

More information

A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human Papillomavirus

A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human Papillomavirus Infectious Diseases in Obstetrics and Gynecology 7:186-189 (1999) (C) 1999 Wiley-Liss, Inc. A Randomized, Double-Blind, Placebo-Controlled Trial of 5-Fluorouracil for the Treatment of Cervicovaginal Human

More information

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer

Promoting Cervical Screening Information for Health Professionals. Cervical Cancer Promoting Cervical Screening Information for Health Professionals Cervical Cancer PapScreen Victoria Cancer Council Victoria 1 Rathdowne St Carlton VIC 3053 Telephone: (03) 635 5147 Fax: (03) 9635 5360

More information

Risk factors for the acquisition of genital warts: are condoms protective?

Risk factors for the acquisition of genital warts: are condoms protective? 312 Sex Transm Inf 1999;75:312 316 Original article Academic Unit of Sexual Health Medicine, Sydney Hospital, Sydney, Australia LMWen C S Estcourt A Mindel Department of Public Health and Community Medicine,

More information

Epidemiology and Natural History of Genital Human Papillomavirus Infection. Bethany A. Weaver, DO, MPH

Epidemiology and Natural History of Genital Human Papillomavirus Infection. Bethany A. Weaver, DO, MPH Human papillomavirus (HPV) is a ubiquitous human pathogen that causes cervical and other anogenital cancers as well as genital warts and recurrent respiratory papillomatosis. Human papillomavirus infection

More information

HUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY

HUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY Int. J. Cancer: 85, 486 491 (2000) 2000 Wiley-Liss, Inc. Publication of the International Union Against Cancer HUMAN PAPILLOMAVIRUS INFECTION AND INVASIVE CERVICAL CANCER IN PARAGUAY Pedro A. ROLÓN 1,

More information

HPV AND CERVICAL CANCER

HPV AND CERVICAL CANCER HPV AND CERVICAL CANCER DR SANDJONG TIECHOU ISAAC DELON Postgraduate Training in Reproductive Health Research Faculty of Medicine, University of Yaoundé 2007 INTRODUCTION CERVICAL CANCER IS THE SECOND

More information

The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus

The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus THE YALE JOURNAL OF BIOLOGY AND MEDICINE 64 (1991), 591-597 The Management of Minor Degrees of Cervical Dysplasia Associated with the Human Papilloma Virus JOHN A. CARMICHAEL, M.D., C.M., F.R.C.S.C. Division

More information

Risk factors in the development of cervical intraepithelial neoplasia in women with vulval warts

Risk factors in the development of cervical intraepithelial neoplasia in women with vulval warts Genitourin Med 1988;64:316-20 Risk factors in the development of cervical intraepithelial neoplasia in women with vulval warts S A WALKINSHAW,* J DODGSON,* D J McCANCE,t I D DUNCAN* From the *Department

More information

Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening

Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening Acta Obstetricia et Gynecologica. 2007; 86: 720 725 ORIGINAL ARTICLE Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening

More information

with That in Simultaneously Collected Urethra and Cervix Samples

with That in Simultaneously Collected Urethra and Cervix Samples JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1993, P. 1975-1979 0095-1137/93/081975-05$02.00/0 Copyright 1993, American Society for Microbiology Vol. 31, No. 8 Human Papillomavirus DNA in Urine Samples Compared

More information

Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women

Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women British Journal of Cancer (2002) 87, 1417 1421 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Low grade squamous intra-epithelial lesions and human papillomavirus infection in Colombian women

More information

MAJOR ARTICLE. Human papillomavirus (HPV) is the cause of cervical cancer and is associated with penile cancer, other anogenital

MAJOR ARTICLE. Human papillomavirus (HPV) is the cause of cervical cancer and is associated with penile cancer, other anogenital MAJOR ARTICLE Associations between Male Anogenital Human Papillomavirus Infection and Circumcision by Anatomic Site Sampled and Lifetime Number of Female Sex Partners Carrie M. Nielson, 1 Melody K. Schiaffino,

More information

Pathology of the Cervix

Pathology of the Cervix Pathology of the Cervix Thomas C. Wright Pathology of the Cervix Topics to Consider Burden of cervical cancer 1 Invasive Cervical Cancer Cervical cancer in world Second cause of cancer death in women Leading

More information

Comparison of Physician- and Self-Collected Genital Specimens for Detection of Human Papillomavirus in Men

Comparison of Physician- and Self-Collected Genital Specimens for Detection of Human Papillomavirus in Men JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2006, p. 513 517 Vol. 44, No. 2 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.2.513 517.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Comparison

More information

- ii - Rights c

- ii - Rights c - ii - Rights c - iii - Preface Preface to the third edition Since the first edition of the HPV Information Centre, GLOBOCAN, one of the landmark products of the International Agency for Research on Cancer

More information

The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus Positive, Cytologically Normal Women Over a 10-Year Period

The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus Positive, Cytologically Normal Women Over a 10-Year Period Published Online First on October 23, 2006 as 10.1158/0008-5472.CAN-06-1057 Research Article The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus Positive, Cytologically Normal

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1999, by the Massachusetts Medical Society VOLUME 341 N OVEMBER 25, 1999 NUMBER 22 TYPE-SPECIFIC PERSISTENCE OF HUMAN PAPILLOMAVIRUS DNA BEFORE THE DEVELOPMENT

More information

Human papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands

Human papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands & 2005 USCAP, Inc All rights reserved 0893-3952/05 $30.00 www.modernpathology.org Human papillomavirus testing as a cytology gold standard: comparing Surinam with the Netherlands Mitchell S Wachtel 1,

More information

Screening for Cervical Cancer. Grand Rounds 1/16/13 Meggan Linck

Screening for Cervical Cancer. Grand Rounds 1/16/13 Meggan Linck Screening for Cervical Cancer Grand Rounds 1/16/13 Meggan Linck Cervical Cancer Worldwide 2 nd most common and 5 th deadliest U.S. 8 th most common 80% occur in developing world Median age at diagnosis

More information

Methods for HPV Detection: Polymerase Chain Reaction Assays

Methods for HPV Detection: Polymerase Chain Reaction Assays Monsonego J (ed): Emerging Issues on HPV Infections: From Science to Practice. Basel, Karger, 2006, pp 63 72 Methods for HPV Detection: Polymerase Chain Reaction Assays Suzanne M. Garland a,b, Sepehr Tabrizi

More information

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer.

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer. Your Power for Health Laboratory Information hr-hpv DNA-Chip Know for sure! PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer. PapilloCheck and

More information

Universal human papillomavirus genotyping by the digene. HPV Genotyping RH and LQ Tests

Universal human papillomavirus genotyping by the digene. HPV Genotyping RH and LQ Tests CHAPTER 5 Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests Daan T. Geraets, Charlotte H. Lenselink, Ruud L.M. Bekkers, Leen-Jan van Doorn, Wim G.V. Quint, Willem J.G.

More information

Abstract Aim To evaluate the presence of high risk human papillomaviruses (HPV) in cervical smears showing intraepithelial neoplasia

Abstract Aim To evaluate the presence of high risk human papillomaviruses (HPV) in cervical smears showing intraepithelial neoplasia J Clin Pathol 1999;52:17 22 17 Department of Gynaecology, Friedrich Schiller University, Bachstr 18, 07740 Jena, Germany I Nindl B Lotz U Endisch A Schneider Department of Pathology, Friedrich Schiller

More information

Edinburgh Research Explorer

Edinburgh Research Explorer Edinburgh Research Explorer Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study Citation for published version: Cuschieri, K, Cubie, H,

More information

Genital prevalence of HPV types and co-infection in men

Genital prevalence of HPV types and co-infection in men ORIGINAL ARTICLE Vol. 40 (1): 67-71, January - February, 2014 doi: 10.1590/S1677-5538.IBJU.2014.01.10 Genital prevalence of HPV types and co-infection in men Marcos P. Freire, Daniel Pires, Raphael Forjaz,

More information

Prevalence of human papillomavirus and Chlamydia trachomatis infection in paired urine and cervical smear samples of Palestinian young women.

Prevalence of human papillomavirus and Chlamydia trachomatis infection in paired urine and cervical smear samples of Palestinian young women. Prevalence of human papillomavirus and Chlamydia trachomatis infection in paired urine and cervical smear samples of Palestinian young women. Walid Salim Basha, PhD Faculty of Human Medicine An-Najah National

More information

HPV-DNA Test Kit in Cervical Scrapes or

HPV-DNA Test Kit in Cervical Scrapes or Infectious Diseases in Obstetrics and Gynecology 2:126-129 (I 994) (C) 1994 Wiley-Liss, Inc. Detection of Human Papillomavirus DNA by AffiProbe HPV-DNA Test Kit in Cervical Scrapes or Biopsies-Histopathologic

More information

Validation of an automated detection platform. for use with the Roche Linear Array HPV Genotyping Test ACCEPTED SEPEHR N.

Validation of an automated detection platform. for use with the Roche Linear Array HPV Genotyping Test ACCEPTED SEPEHR N. JCM Accepts, published online ahead of print on September 00 J. Clin. Microbiol. doi:./jcm.0-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

More information

Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women Determined by PCR-DNA Sequencing

Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women Determined by PCR-DNA Sequencing Journal of Bacteriology and Virology 2009. Vol. 39, No. 4 p.337 344 DOI 10.4167/jbv.2009.39.4.337 Original Article Prevalence of Human Papillomavirus Genotypes in Routine Pap Smear of 2,562 Korean Women

More information

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases

Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases British Journal of Cancer (2011) 104, 685 692 All rights reserved 0007 0920/11 www.bjcancer.com Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases MGök 1, L Rozendaal

More information

Relationship between circumcision and human papillomavirus infection: a systematic review and meta analysis

Relationship between circumcision and human papillomavirus infection: a systematic review and meta analysis (2017) 19, 125 131 2017 AJA, SIMM & SJTU. All rights reserved 1008-682X www.asiaandro.com; www.ajandrology.com Male Health Open Access ORIGINAL ARTICLE Relationship between circumcision and human papillomavirus

More information

Anogenital warts: epidemiology, treatment and association with cervical atypia

Anogenital warts: epidemiology, treatment and association with cervical atypia The Ulster Medical Journal, Volume 56, No. 2, pp. 104-108, October 1987. Anogenital warts: epidemiology, treatment and association with cervical atypia W W Dinsmore, T Horner, H Chambers, R D Maw Accepted

More information

Prevalence and determinants of HPV infection among Colombian women with normal cytology

Prevalence and determinants of HPV infection among Colombian women with normal cytology British Journal of Cancer (2002) 87, 324 333 ª 2002 Cancer Research UK All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Prevalence and determinants of HPV infection among Colombian women with normal

More information

SIGNIFICANCE OF MOLECULAR DIAGNOSTICS IN HUMAN PAPILLOMA VIRUS (HPV) DETERMINATION

SIGNIFICANCE OF MOLECULAR DIAGNOSTICS IN HUMAN PAPILLOMA VIRUS (HPV) DETERMINATION Arch. Biol. Sci., Belgrade, 66 (1), 51-56, 2014 DOI:10.2298/ABS1401051K SIGNIFICANCE OF MOLECULAR DIAGNOSTICS IN HUMAN PAPILLOMA VIRUS (HPV) DETERMINATION G. KOVAČEVIĆ 1, V. MILOŠEVIĆ 1, I. HRNJAKOVIĆ-CVJETKOVIĆ

More information

Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia

Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia Brazilian Journal of Medical and Biological Research (2006) 39: 177-187 Male genital infection with human papillomavirus ISSN 0100-879X 177 Infection with human papillomaviruses of sexual partners of women

More information

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at

About HPV. Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. Theree are more than 100 types of HPV, of which at Cervical Cancer & HPV What is HPV Human papillomavirus (HPV) is a group of viruses that are extremely common worldwide. About HPV Theree are more than 100 types of HPV, of which at least 13 are cancer-causing

More information

Human Papillomavirus

Human Papillomavirus Human Papillomavirus Dawn Palaszewski, MD Assistant Professor of Obstetrics and Gynecology University of February 18, 2018 9:40 am Dawn Palaszewski, MD Assistant Professor Department of Obstetrics and

More information

Chapter 4. Triaging HPV-positive women with normal cytology by p16/ki-67 dual-stained cytology testing: Baseline and longitudinal data

Chapter 4. Triaging HPV-positive women with normal cytology by p16/ki-67 dual-stained cytology testing: Baseline and longitudinal data Chapter 4 Triaging HPV-positive women with normal cytology by p16/ki-67 dual-stained cytology testing: Baseline and longitudinal data Margot H. Uijterwaal Nicole J. Polman Birgit I. Witte Folkert J. Van

More information

Papers. Abstract. Introduction. Methods

Papers. Abstract. Introduction. Methods Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study Susanne

More information

HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS

HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS HUMAN PAPILLOMAVIRUS INFECTION IN WOMEN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS XIAO-WEI SUN, M.D., LOUISE KUHN, PH.D., TEDD V. ELLERBROCK, M.D., MARY ANN CHIASSON, DR.P.H., TIMOTHY J. BUSH, B.A.,

More information

Human papilloma viruses and cancer in the post-vaccine era

Human papilloma viruses and cancer in the post-vaccine era REVIEW 10.1111/j.1469-0691.2009.03032.x Human papilloma viruses and cancer in the post-vaccine era E. Galani and C. Christodoulou Metropolitan Hospital Medical Oncology, Athens, Greece Abstract Human papilloma

More information

Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study

Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study American Journal of Epidemiology Copyright 2003 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 158, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwg171 Determinants of Clearance

More information

Diagnosis of genital human papillomavirus (HPV) lesions in the male: Correlation of peniscopy, histology and in situ hybridisation

Diagnosis of genital human papillomavirus (HPV) lesions in the male: Correlation of peniscopy, histology and in situ hybridisation 346 Genitourin Med 1993;69:346-351 Diagnosis of genital human papillomavirus (HPV) lesions in the male: Correlation of peniscopy, histology and in situ hybridisation M I Hippelainen, S Syrjfnen, M J Hippelainen,

More information

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted? CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Human Papillomaviruses

More information

Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study

Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study Research Article Human papiloma virus testing in the cervix of high-risk women: A hospital-based clinicopathological, colposcopic, and cytogenetic study Subhash Bhardwaj 1, Farooq Ahmed Wani 2, Altaf Bandy

More information

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent

More information

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

and treating joins with the top of canal). at risk for cervical carcinomas, cervix. CERVICAL CANCER Worldwide, cervical cancer is twelfth most common and the fifth most deadly cancer in women. It affects about 16 per 100,000 women per year and kills about 9 per 100,000 per year. Cervical

More information

Leukocyte Ultrafiltrate

Leukocyte Ultrafiltrate Infectious Diseases in Obstetrics and Gynecology 8:120-123 (2000) (C) 2000 Wiley-Liss, Inc. Immunotherapy of Gynaecological High-Risk Human Papilloma Virus Infection With Human Leukocyte Ultrafiltrate

More information

HPV Epidemiology and Natural History

HPV Epidemiology and Natural History HPV Epidemiology and Natural History Rachel Winer, PhD, MPH Associate Professor Department of Epidemiology University of Washington School of Public Health rlw@uw.edu Human Papillomavirus (HPV) DNA virus

More information

Opinion: Cervical cancer a vaccine preventable disease

Opinion: Cervical cancer a vaccine preventable disease Opinion: Cervical cancer a vaccine preventable disease Leon Snyman Principal specialist at the Department of Obstetrics and Gynaecology, Gynaecological Oncology unit, University of Pretoria and Kalafong

More information

Human Papillomavirus in Squamous Cell Carcinoma of Esophagus in a High-Risk Population

Human Papillomavirus in Squamous Cell Carcinoma of Esophagus in a High-Risk Population Human Papillomavirus in Esophageal Cancer Tahmasebi Fard Z Department of Molecular Biology, Khatam Postgraduate Faculty, Tehran Farhadi Langroody M Shahrara Medical Laboratory, Tehran Malekzadeh R Digestive

More information

The implications of HPV immunisation on cervical screening

The implications of HPV immunisation on cervical screening The implications of HPV immunisation on cervical screening Dr Maggie Cruickshank Senior Lecturer in Gynaecology Scottish Cervical Cancer Prevention Programme (SCCPP) funded by CSO Cervical screening Detects

More information

Human Papilloma Viruses HPV Testing and Treatment of STDs

Human Papilloma Viruses HPV Testing and Treatment of STDs Human Papilloma Viruses HPV Testing and Treatment of STDs New York State Collaborative Efforts in Medical Evaluations of Child and Adolescent Sexual Offenses. Child and Adolescent Sexual Offense Post-Assault

More information

The devil is in the details

The devil is in the details The cobas KNOW THE RISK For cervical cancer prevention The devil is in the details Leading with the cobas as your primary screening method uncovers disease missed by cytology, and can protect women from

More information

Prevalence of Penile Human Papillomavirus DNA in Husbands of Women with and without Cervical Neoplasia: A Study in Spain and Colombia

Prevalence of Penile Human Papillomavirus DNA in Husbands of Women with and without Cervical Neoplasia: A Study in Spain and Colombia 353 Prevalence of Penile Human Papillomavirus DNA in Husbands of Women with and without Cervical Neoplasia: A Study in Spain and Colombia X. Castellsagué, A. Ghaffari, R. W. Daniel, F. X. Bosch, Servei

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 22 by the Massachusetts Medical Society VOLUME 346 A PRIL 11, 22 NUMBER 15 MALE CIRCUMCISION, PENILE HUMAN PAPILLOMAVIRUS INFECTION, AND CERVICAL CANCER IN

More information

Articles. Funding Zorg Onderzoek Nederland (Netherlands Organisation for Health Research and Development).

Articles. Funding Zorg Onderzoek Nederland (Netherlands Organisation for Health Research and Development). Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASAM randomised controlled trial Dorien Rijkaart, Johannes Berkhof, Lawrence

More information

THE PERFORMANCE OF CEPHEID XPERT HPV

THE PERFORMANCE OF CEPHEID XPERT HPV THE PERFORMANCE OF CEPHEID XPERT HPV Zizipho Z.A Mbulawa, Timothy Wilkin, Bridgette J. Goeieman, Eefje Jong, Pamela Michelow, Avril Swarts, Jennifer S. Smith, Patricia Kegorilwe, Cynthia S. Firnhaber,

More information

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal

Department of Pathology, Kathmandu Medical College & Teaching Hospital, Sinamangal, Kathmandu, Nepal Kathmandu University Medical Journal (2007), Vol. 5, No. 4, Issue 20, 461-467 Original Article Correlation of PAP smear findings with clinical findings and cervical biopsy Pradhan B 1, Pradhan SB 2, Mital

More information

Learning Objectives. What is HPV? Incidence in the U.S. 5/22/2013. Human papillomavirus Infections

Learning Objectives. What is HPV? Incidence in the U.S. 5/22/2013. Human papillomavirus Infections Human papillomavirus Infections Anne Rompalo, MD, ScM Professor of Medicine Learning Objectives By the end of the presentation the participants will be able to: Describe the role of persistent HPV infection

More information

Shrestha P CORRESPONDENCE

Shrestha P CORRESPONDENCE NJOG 2015 Jul-Dec; 20 (2):45-49 Original Article Shrestha P 1 2 2 1 Department of Obstetrics and Gynecology, Patan Academy of Health Science, Lalitpur, 2 Department of Obstetrics and Gynecology, Tribhuvan

More information

Journal of Clinical Virology

Journal of Clinical Virology Journal of Clinical Virology 54 (2012) 147 151 Contents lists available at SciVerse ScienceDirect Journal of Clinical Virology j ourna l ho mepage: www.elsevier.com/locate/jcv Brush-based self-sampling

More information

HUMAN PAPILLOMAVIRUS TESTING

HUMAN PAPILLOMAVIRUS TESTING CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS HUMAN PAPILLOMAVIRUS TESTING Policy Number: PDS - 016 Effective Date: October 1, 2018

More information

Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIVpositive

Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIVpositive ecommons@aku Pathology, East Africa Medical College, East Africa September 2013 Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIVpositive women in Kenya Hugo De Vuyst

More information

Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea

Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea RESEARCH COMMUNICATION Prevalence and Determinants of High-risk Human Papillomavirus Infection in Women with High Socioeconomic Status in Seoul, Republic of Korea Kidong Kim 1, Jin Ju Kim 2,3, Sun Mie

More information

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim Is vaccination with quadrivalent HPV vaccine after Loop Electrosurgical Excision Procedure effective in preventing recurrence in patients with High-grade Cervical Intraepithelial Neoplasia (CIN2-3)? Chonnam

More information

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates

More information

Chapter 2: Disease Burden and Cervical Screening in Ontario

Chapter 2: Disease Burden and Cervical Screening in Ontario Chapter 2: Disease Burden and Cervical Screening in Ontario Learning Objectives On completion of this section, the learner will be able to: 1. Understand human papillomavirus, disease burden, cervical

More information

The epidemiology of human papillomavirus infection and cervical cancer

The epidemiology of human papillomavirus infection and cervical cancer Disease Markers 23 (2007) 213 227 213 IOS Press The epidemiology of human papillomavirus infection and cervical cancer F. Xavier Bosch and Silvia de Sanjosé Institut Català d Oncologia, Epidemiology and

More information

The clearest path to the most meaningful results. The cobas HPV Test delivers clinical value with workflow efficiencies every step of the way

The clearest path to the most meaningful results. The cobas HPV Test delivers clinical value with workflow efficiencies every step of the way The clearest path to the most meaningful results The cobas HPV Test delivers clinical value with workflow efficiencies every step of the way The cobas HPV Test KNOW THE RISK Help guide clinical decision

More information

Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men

Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men MAJOR ARTICLE Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men Bethany A. Weaver, 1 Qinghua Feng, 2 King K. Holmes, 1 Nancy Kiviat, 2,3 Shu-Kuang Lee,

More information

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer The new england journal of medicine original article Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer Nubia Muñoz, M.D., F. Xavier Bosch, M.D., Silvia de Sanjosé,

More information

Ajmal Akbari 1, Davy Vanden Broeck 1,2,3,4*, Ina Benoy 1,2,4, Elizaveta Padalko 2,5, Johannes Bogers 1,2,3,4 and Marc Arbyn 6

Ajmal Akbari 1, Davy Vanden Broeck 1,2,3,4*, Ina Benoy 1,2,4, Elizaveta Padalko 2,5, Johannes Bogers 1,2,3,4 and Marc Arbyn 6 Akbari et al. Virology Journal (2018) 15:166 https://doi.org/10.1186/s12985-018-1076-6 RESEARCH Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international

More information

Received 14 December 2005/Returned for modification 17 February 2006/Accepted 1 May 2006

Received 14 December 2005/Returned for modification 17 February 2006/Accepted 1 May 2006 JOURNAL OF CLINICAL MICROBIOLOGY, July 2006, p. 2428 2433 Vol. 44, No. 7 0095-1137/06/$08.00 0 doi:10.1128/jcm.02608-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Assessment

More information

Natural History of HPV Infections 15/06/2015. Squamous cell carcinoma Adenocarcinoma

Natural History of HPV Infections 15/06/2015. Squamous cell carcinoma Adenocarcinoma 14,670 5796 United States/ Canada 17,165 8124 Central America 48,328 21,402 South America 59,929 29,814 Europe 78,896 61,670 Africa 157,759 86,708 Southcentral Asia 61,132 31,314 Eastern Asia 42,538 22,594

More information

These comments are an attempt to summarise the discussions at the manuscript meeting. They are not an exact transcript.

These comments are an attempt to summarise the discussions at the manuscript meeting. They are not an exact transcript. Dear dr. Weber, We would like to thank you for the review of our manuscript entitled Cervical screening with an interval beyond five years requires different rescreen times for HPV-negative and HPVpositive,

More information

From cytology to full molecular cervical screening

From cytology to full molecular cervical screening From cytology to full molecular cervical screening Chris JLM.Meijer Dept of Pathology Vrije Universiteit Medical Center Amsterdam The Netherlands cjlm.meijer@vumc.nl Cervical cancer worldwide Worldwide:

More information

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer original article Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer Pontus Naucler, M.D., Ph.D., Walter Ryd, M.D., Sven Törnberg, M.D., Ph.D., Anders Strand, M.D., Ph.D., Göran Wadell,

More information

anogenital warts A colposcopic case-control study of cervical squamous intraepithelial lesions in women with Conclusions-Anogenital warts are not a

anogenital warts A colposcopic case-control study of cervical squamous intraepithelial lesions in women with Conclusions-Anogenital warts are not a 300 Department of Genitourinary Medicine, Charing Cross Hospital, London, W6 8RF B A Evans Charing Cross and Westminster Medical School, Charing Cross Hospital, London, W6 8RF R A Bond K D MacRae Address

More information

He Said, She Said: HPV and the FDA. Audrey P Garrett, MD, MPH June 6, 2014

He Said, She Said: HPV and the FDA. Audrey P Garrett, MD, MPH June 6, 2014 He Said, She Said: HPV and the FDA Audrey P Garrett, MD, MPH June 6, 2014 Disclosure Speaker for Merck Gardasil Speaker for Hologic Thin Prep and Cervista Cervical Cancer Screening: 21 st century Dr. Papanicolaou

More information

SCCPS Scientific Committee Position Paper on HPV Vaccination

SCCPS Scientific Committee Position Paper on HPV Vaccination SCCPS Scientific Committee Position Paper on HPV Vaccination Adapted from Joint Statement (March 2011) of the: Obstetrical & Gynaecological Society of Singapore (OGSS) Society for Colposcopy and Cervical

More information

Department of Medical Virology University of Pretoria; National Health Laboratory Service; and 5

Department of Medical Virology University of Pretoria; National Health Laboratory Service; and 5 Unique Human PapillomavirusYType Distribution in South African Women With Invasive Cervical Cancer and the Effect of Human Immunodeficiency Virus Infection Matthys Cornelis van Aardt, FCOG(SA), 1* Greta

More information

Biomarkers and HPV testing: The future of cervical screening

Biomarkers and HPV testing: The future of cervical screening THE FUTURE OF CERVICAL SCREENING Earn 3 CPD Points online Biomarkers and HPV testing: The future of cervical screening Professor John O Leary Associate Professor and Director of Pathology Coombe Women

More information

Human Papillomavirus Genotyping Using an Automated Film-Based Chip Array

Human Papillomavirus Genotyping Using an Automated Film-Based Chip Array JMD CME Program Journal of Molecular Diagnostics, Vol. 11, No. 5, September 2009 Copyright American Society for Investigative Pathology and the Association for Molecular Pathology DOI: 10.2353/jmoldx.2009.080154

More information

Focus. A case. I have no conflicts of interest. HPV Vaccination: Science and Practice. Collaborative effort with Karen Smith-McCune, MD, PhD 2/19/2010

Focus. A case. I have no conflicts of interest. HPV Vaccination: Science and Practice. Collaborative effort with Karen Smith-McCune, MD, PhD 2/19/2010 HPV Vaccination: Science and Practice George F. Sawaya, MD Professor Department of Obstetrics, Gynecology and Reproductive Sciences Department of Epidemiology and Biostatistics Director, Colposcopy Clinic,

More information

Original Policy Date

Original Policy Date MP 2.04.03 Cervicography Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to Medical Policy Index Disclaimer

More information

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions British Journal of Cancer (2000) 83(5), 561 565 doi: 10.1054/ bjoc.2000.1375, available online at http://www.idealibrary.com on A systematic review of the role of human papilloma virus (HPV) testing within

More information